Floatz logo

ISOFLURANE

Delirium

Duke UniversitySmall moleculePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Delirium cohort.

View all 22

Same molecule, other indications

ISOFLURANE is also rated in:

subarachnoid hemorrhageDormant
BB
Indicative · Phase 4
66 / 100
View asset →
prostate cancerDormant
BB
Indicative · Phase 4
66 / 100
View asset →
lung cancerDormant
BB
Indicative · Phase 4
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →